Hindustan Unilever Ltd. share price target

HUL's performance during the quarter was stable due to strong execution abilities, *over or under performance to benchmark index GST adjustments and a moderate seasonal environment. GST cuts are expected to support consumption recovery and improve channel momentum during the festive period. HUL's strategic focus on premiumisation, science-led innovation and digital acceleration continues to reinforce brand leadership across key categories. By expanding its e-commerce presence and by using data-led marketing and supply chain digitisation, the company has enhanced execution agility and consumer reach....

Broadly as estimated amid the GST rate-cut transition and a prolonged monsoon, HUL’s Q2FY26 performance was weak. Revenue inched up ~1% y/y to Rs155bn (vs. the Street’s Rs158bn estimate) with flat volumes and a 22.9% EBITDA margin (vs. 22.2%).

About the stock: Hindustan Unilever (HUL) is India's largest FMCG company with presence of more than 90 years. The company has portfolio of 50+ brands spanning to various categories such as detergents, personal wash and skin care & colour cosmetics. 80% of revenues come from products having leadership positioning in...

With a 6% upside from the CMP, we maintain our HOLD rating on the stock.

We expect the Company to outperform in H1FY26E over H2FY25, led by stronger volume offtake aided by continued transformation in the and on the back of improving macro tailwinds.

With a 7% upside from the CMP, we maintain our HOLD rating on the stock

HUL’s standalone revenue grew by 3.9% y-o-y to Rs. 15,931 crore, largely in line with our and average street expectations of Rs. 15,954 crore and Rs. 16,065 crore, respectively. Domestic volume grew by 3% y-o-y.

Hindustan Unilever’s (HUVR) 1QFY26 consolidated revenue was up 5% at INR165.1b (in line), with underlying volume growth (UVG) of 4% (est. 3% and 2% in 4QFY25), led by a steady recovery in rural markets (~1/3 of portfolio) and a gradual improvement in urban demand.

Hindustan Unilever (HUVR) announced that Ms. Priya Nair, current President of Beauty & Wellbeing at Unilever, will be appointed CEO and MD of the company, effective 1st Aug’25, for a period of five years.

4QFY25 sales were in line, but EBITDA 2% ahead of Bloomberg consensus

With an 8% upside from the CMP, we maintain HOLD

We cut FY26/FY27EPS by 3.1/3% factoring in 80/50bps cut in margins to 22.7/23.3% in FY26/27 as HUVR transitions through the inflationary phase and invests in Innovation, new products, A&P, distribution channel etc. to push for growth as it expects demand recovery to set in. HUL continues to focus on transforming its portfolio contribution from Core to Future Core & Market Mover. HUVR is making a big push in premium segments in Beauty and wellbeing to regain lost ground by acquisitions and new launches, which should start showing impact by end of 1H26. HFD turnaround seems tough given...

Hindustan Unilever’s (HUVR) 4QFY25 consolidated revenue was up 3% at INR154.5b (in line), with 2% underlying volume growth (est. 1%, 0% in 3QFY25). Rural demand continues to show gradual improvement, while urban demand remains subdued.

HUL’s Q4 was broadly in line with the Street’s expectations, with volumes growing 2% y/y (vs. 0-2% estimated) and the EBITDA margin at 22.8% (vs. 23%).

Compared to Bloomberg consensus, 3QFY25 sales were in line, while EBITDA was 1% higher

With an 8% upside from the CMP, we downgrade the stock to HOLD

HUL’s Q3FY25 performance was in line with expectations, with revenues growing by 1.4% y-o-y to Rs. 15,408 crore (versus expectation of Rs. 15,682 crore) with underlying volumes flat y-o-y. Homecare revenues grew by 5.4% y-o-y (high single-digit volume growth), beauty & well-being revenues grew by 1.4% y-o-y (low single-digit volume decline), personal care revenue declined by 3% y-o-y (mid single-digit volume decline), while foods & refreshments revenue stood flat y-o-y (mid single-digit volume decline).

Hindustan Unilever’s (HUVR) 3QFY25 revenue was up 2% at INR155.9b (in line), with flat underlying volume growth (est. 1%, 3% in 2QFY25). Demand recovery continues to witness a delay, with urban consumption reeling under pressure.

We retain our positive stance on HUL, despite a sub-par financial performance and muted near-term demand outlook. Medium term, we see HUL’s enhanced execution absorbing the impact of macro stress (if it persists).